# Observational Program, Study the Preventive Efficacy of the BiVac Polio Vaccine Against the Incidence of Acute Respiratory Infections, Including COVID-19

> **NCT05083039** · — · COMPLETED · sponsor: **Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products** · enrollment: 1500 (actual)

## Conditions studied

- Coronavirus Infections
- Vaccine
- Polio

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05083039
- **Lead sponsor:** Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-14
- **Primary completion:** 2020-12-14
- **Final completion:** 2021-09-03
- **Target enrollment:** 1500 (ACTUAL)
- **Last updated:** 2023-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05083039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05083039, "Observational Program, Study the Preventive Efficacy of the BiVac Polio Vaccine Against the Incidence of Acute Respiratory Infections, Including COVID-19". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT05083039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*